Promacta
PHONETIC PRONUNCIATION: Promacta
Description
Promacta (eltrombopag) is a medication used to treat low platelet counts in patients with chronic immune thrombocytopenia (ITP), a condition that affects the body's ability to produce enough platelets. This condition can lead to excessive bleeding and bruising, which can be dangerous. Promacta works by stimulating the production of platelets in the bone marrow, thereby increasing the number of platelets in the blood. Uses Promacta is primarily used for the treatment of chronic ITP. It is also used to treat thrombocytopenia (low platelet count) in patients with chronic hepatitis C who are undergoing antiviral treatment. Additionally, Promacta has been shown to be effective in treating severe aplastic anemia. Dosage The dosage of Promacta varies depending on the patient's weight and medical history. The typical starting dose is 50 mg once daily, which may be increased to a maximum of 75-150 mg once daily based on the patient's response. The medication should be taken at the same time each day with or without food. Demographic Promacta is indicated for use in adults and children who are at least 1 year old. However, it should not be used in patients with a history of liver problems or in patients who have developed a blood clot while using Promacta. Side Effects The most common side effects associated with Promacta include headache, fatigue, nausea, diarrhea, and abdominal pain. Additionally, patients may experience muscle and joint pain and an increased risk of upper respiratory tract infections. In rare cases, patients may experience serious side effects, such as liver problems and blood clots. Interactions Promacta may interact with other medications, such as antacids, calcium supplements, and certain antibiotics. It is important to inform your doctor of all medications you are currently taking to avoid any potential drug interactions. Generic Options There is currently no generic version of Promacta available on the market. However, there are other medications that are used to treat low platelet counts, such as corticosteroids and immunosuppressants. It is important to talk to your doctor about all treatment options available to you. In conclusion, Promacta is an effective medication for increasing platelet counts in patients with chronic ITP and other related conditions. While it may cause some side effects, it is generally well-tolerated by patients. It is important to take the medication as prescribed and inform your doctor of any other medications you are taking to avoid any potential interactions.
Faq for Promacta
Promacta is used for the treatment of certain blood disorders, including chronic immune thrombocytopenia (ITP) and severe aplastic anemia (SAA).
Promacta is a thrombopoietin receptor agonist that helps to increase platelet production in the body. It stimulates the production of more platelets, which are needed for blood clotting.
The common side effects of Promacta may include nausea, vomiting, diarrhea, headache, muscle or joint pain, dizziness, and changes in taste.
Promacta should be taken exactly as prescribed by the healthcare provider. It is usually taken once a day, with or without food. The tablets should be swallowed whole and not crushed or chewed.
It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements. Some medications may interact with Promacta, so it's essential to consult with your doctor.
The effectiveness of Promacta varies from person to person. In most cases, noticeable improvement in symptoms can be seen within a few weeks of starting the medication. However, it may take several months to reach the desired platelet count.
Promacta should be used during pregnancy only when clearly needed. It is important to discuss the potential risks and benefits with your healthcare provider beforehand.
Yes, Promacta is approved for use in children aged 1 year and older with chronic immune thrombocytopenia (ITP) who have not responded well to other treatments.
During treatment with Promacta, your healthcare provider will regularly monitor your blood cell counts through frequent blood tests to ensure the medication is working effectively and to identify any potential side effects.
Promacta should not be stopped abruptly without consulting your healthcare provider. The dosage may need to be gradually reduced before discontinuing the medication to prevent any adverse effects.